DOI QR코드

DOI QR Code

Comparison of Clinical and Radiologic Characteristics between Anthracofibrosis and Endobronchial Lung Cancer

  • Yun, Seo Young (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center) ;
  • Park, Tae Yun (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center)
  • Received : 2020.12.05
  • Accepted : 2021.05.03
  • Published : 2021.07.31

Abstract

Background: Endobronchial lung cancer (EBLC) and bronchial anthracofibrosis (BAF) share similar symptoms and radiological findings. The aim of this study was to describe clinical and radiological differences between BAF and EBLC, both of which were confirmed by bronchoscopy. Methods: This was a retrospective study of patients with BAF or EBLC from 2008 to 2014. Data were derived from a bronchoscopy registry made since January 1, 2008. Clinical and radiological characteristics of both diseases were analyzed. Results: Among 3,214 patients who underwent bronchoscopy, 167 and 117 patients were enrolled in BAF and EBLC groups, respectively. BAF occurred more predominantly in older non-smoking female patients with a higher chance of tuberculosis (38.3%) than EBLC (6.0%). Cough, sputum, and dyspnea were common symptoms reported for both groups. Bronchoscopic findings revealed that BAF lesions were more common in multiple lobar bronchi (85.0%) or bilateral bronchi (73.7%). Radiologic findings revealed that bronchial stenosis was the most commonly found lesion in both groups (49.1% and 78.6%, respectively). Rates of peribronchial calcification and bronchial wall thickening were higher in the BAF group. The number of patients with lymph node calcification was also higher in the BAF group. Conclusion: Results of this study demonstrated characteristics of clinical and radiologic findings of BAF and EBLC. Increasing the awareness of both diseases may help clinicians differentiate these two diseases from each other, thus avoiding unnecessary invasive diagnostic procedures.

Keywords

References

  1. Chung MP, Lee KS, Han J, Kim H, Rhee CH, Han YC, et al. Bronchial stenosis due to anthracofibrosis. Chest 1998;113: 344-50. https://doi.org/10.1378/chest.113.2.344
  2. Jang SJ, Lee SY, Kim SC, Lee SY, Cho HS, Park KH, et al. Clinical and radiological characteristics of non-tuberculous bronchial anthracofibrosis. Tuberc Respir Dis 2007;63:139-44. https://doi.org/10.4046/trd.2007.63.2.139
  3. Sigari N, Mohammadi S. Anthracosis and anthracofibrosis. Saudi Med J 2009;30:1063-6.
  4. Matthews JI, Matarese SL, Carpenter JL. Endobronchial tuberculosis simulating lung cancer. Chest 1984;86:642-4. https://doi.org/10.1378/chest.86.4.642
  5. Smith LS, Schillaci RF, Sarlin RF. Endobronchial tuberculosis: serial fiberoptic bronchoscopy and natural history. Chest 1987;91:644-7. https://doi.org/10.1378/chest.91.5.644
  6. No TM, Kim IS, Kim SW, Park DH, Joeng JK, Ju DW, et al. The clinical investigation for determining the etiology of bronchial anthracofibrosis. Korean J Med 2003;65:665-74.
  7. Kim YJ, Jung CY, Shin HW, Lee BK. Biomass smoke induced bronchial anthracofibrosis: presenting features and clinical course. Respir Med 2009;103:757-65. https://doi.org/10.1016/j.rmed.2008.11.011
  8. Hwang J, Puttagunta L, Green F, Shimanovsky A, Barrie J, Long R. Bronchial anthracofibrosis and tuberculosis in immigrants to Canada from the Indian subcontinent. Int J Tuberc Lung Dis 2010;14:231-7.
  9. Mirsadraee MH, Asnashari AK, Attaran DM. Tuberculosis in patients with anthracosis of lung underlying mechanism or superimposed disease. Iran Red Crescent Med J 2011;13:670-3.
  10. Mirsadraee M, Saffari A, Sarafraz Yazdi M, Meshkat M. Frequency of tuberculosis in anthracosis of the lung: a systematic review. Arch Iran Med 2013;16:661-4.
  11. Kako K, Sakakibara H, Satou M, Suetsugu S. Management of mycobacteriosis in general hospital without isolation ward for tuberculosis patients. 4. Actual status of the management of tuberculosis patients in a university hospital without isolation wards for infectious diseases. Kekkaku 1999;74:145-50.
  12. Jung SW, Kim YJ, Kim GH, Kim MS, Son HS, Kim JC, et al. Ventilatory dynamics according to bronchial stenosis in bronchial anthracofibrosis. Tuberc Respir Dis 2005;59:368-73. https://doi.org/10.4046/trd.2005.59.4.368
  13. Lee HS, Maeng JH, Park PG, Jang JG, Park W, Ryu DS, et al. Clinical features of simple bronchial anthracofibrosis which is not associated with tuberculosis. Tuberc Respir Dis 2002;53:510-8. https://doi.org/10.4046/trd.2002.53.5.510
  14. Fawibe AE, Salami AK, Oluboyo PO, Desalu OO, Odeigha LO. Profile and outcome of unilateral tuberculous lung destruction in Ilorin, Nigeria. West Afr J Med 2011;30:130-5.
  15. Kim HY, Im JG, Goo JM, Kim JY, Han SK, Lee JK, et al. Bronchial anthracofibrosis (inflammatory bronchial stenosis with anthracotic pigmentation): CT findings. AJR Am J Roentgenol 2000;174:523-7. https://doi.org/10.2214/ajr.174.2.1740523
  16. Mirsadraee M, Asna-Ashari A, Attaran D, Naghibi S, Mirsadraee S. Bronchial anthracosis: a new diagnosis for benign mass lesions of the lung. Tanaffos 2013;12:10-8.
  17. Han FF, Yang TY, Song L, Zhang Y, Li HM, Guan WB, et al. Clinical and pathological features and imaging manifestations of bronchial anthracofibrosis: the findings in 15 patients. Chin Med J (Engl) 2013;126:2641-6.
  18. Kim MH, Lee HY, Nam KH, Lim JM, Jung BH, Ryu DS. The clinical significance of bronchial anthracofibrosis associated with coal workers' pneumoconiosis. Tuberc Respir Dis 2010;68:67-73. https://doi.org/10.4046/trd.2010.68.2.67
  19. Storer J, Smith RC. The calcified hilar node: its significance and management: a review. Am Rev Respir Dis 1960;81:858-67.
  20. Price LW. The pathology of lymph node enlargement. Postgrad Med J 1947;23:401-25. https://doi.org/10.1136/pgmj.23.263.401
  21. Ooi CG, Khong PL, Cheng RS, Tan B, Tsang F, Lee I, et al. The relationship between mediastinal lymph node attenuation with parenchymal lung parameters in silicosis. Int J Tuberc Lung Dis 2003;7:1199-206.
  22. Marchiori E, Hochhegger B, Zanetti G. Lymph node calcifications. J Bras Pneumol 2018;44:83. https://doi.org/10.1590/s1806-37562018000000003
  23. Gawne-Cain ML, Hansell DM. The pattern and distribution of calcified mediastinal lymph nodes in sarcoidosis and tuberculosis: a CT study. Clin Radiol 1996;51:263-7. https://doi.org/10.1016/S0009-9260(96)80343-6
  24. Weber AL, Bird KT, Janower ML. Primary tuberculosis in childhood with particular emphasis o hanges affecting the tracheobronchial tree. Am J Roentgenol Radium Ther Nucl Med 1968;103:123-32. https://doi.org/10.2214/ajr.103.1.123
  25. Eisenkraft BL, Som PM. The spectrum of benign and malignant etiologies of cervical node calcification. AJR Am J Roentgenol 1999;172:1433-7. https://doi.org/10.2214/ajr.172.5.10227533
  26. Kim MA, Lee JC, Choi CM. Bronchial anthracofibrosis and macroscopic tissue pigmentation on EBUS-TBNA predict a low probability of metastatic lymphadenopathy in Korean lung cancer patients. J Korean Med Sci 2013;28:383-7. https://doi.org/10.3346/jkms.2013.28.3.383